Silence Therapeutics plc (SLNCF)
Market Closed
17 Jul, 20:00
OTC PINK OTC PINK Primary $
1. 50
0
0%
$
212.56M Market Cap
- P/E Ratio
- Div Yield
15,832 Volume
0 Eps
$ 1.5
Previous Close Want to track SLNCF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Silence Therapeutics plc (SLNCF) Statistics
Valuation metrics
Market Cap 212.56M
Enterprise value 490.44M
Trailing P/E (ttm) -2.43
Forward P/E -
PEG ratio 0.09
Price/Sales (ttm) 538.21
Price/Book (mrq) 10.04
Enterprise Value/Revenue 532.22
Enterprise Value/EBITDA -6.28
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 5.94K
Average volume (90 days) 1.49K
Price summary
52-Week low 1.06
52-Week high 2.63
Beta -
50-Day moving average 1.61
200-Day moving average 1.76
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:50
Last split Date 30 Apr 2013
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -92.43%
Operating margin -93.97%
Operational effectiveness
Return on assets -0.74%
Return on equity -1.22%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.8
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.48
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 9.83%
Book value per share (mrq) 1.05
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
